TLRY vs WY · rev $915.5M vs P/E 43, rev $3.59B
Tilray Inc (TLRY) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
TLRY currently screens at market cap $573.9M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the TLRY and WY stock pages for the full models.
Not investment advice.